leisure time -WSS

leisure time

author：entertainment 2025-09-06 03:40:07 - browse：555

Ed Silverman on the Breakthrough Summit stage in 2023. — STAT's Ed Silverman on stage at the STAT Breakthrough Summit in 2023. Sarah Gonzalez for STAT

In 2023, STAT launched a brand-new home for our subscribers to connect with each other and with their favorite STAT journalists. On STAT+ Connect, you can find job postings; comment on STAT articles (since we have closed comments on article pages); discuss industry events with other people who work in biotech, pharma, public health advocacy, PR, and more; read insights and exclusive material posted by STAT reporters and editors; and watch events, including live interviews and text-based Ask Me Anything chats.

Last week, Ed Silverman, AKA Pharmalot, hosted an AMA titled “Stump Pharmalot.” During the AMA, Ed discussed gene therapy, his proudest career moments, what he took in high school instead of chemistry, coffee (or, as he calls it, “cups of stimulation”), and more.

Below, you can find a lightly edited transcript of the conversation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Abridge raises $150m as clinical notes automation market heats up

knowledge

WSS

Ebola: Gilead Sciences antiviral shows promise as new treatment

New study raises questions about niacin and heart health

Elevance, SCAN deals highlight health insurer acquisition scrutiny

How many hemophilia patients actually want gene therapy?

Measles policy set amid Florida outbreak alarms vaccine proponents

Obamacare plans could cover weight loss drugs

knowledge

leisure time

Wikipedia

The cancer drug shortage isn’t new — and neither are the solutions

Medicare coverage of Wegovy, once blocked, now looks possible

Activists slam private health insurers over coverage restrictions

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Bright Health sells Medicare Advantage business to Molina

FDA warns medical device makers about rise in fabricated data

Virginia high school admissions case could be legal follow

As AI regulations shape up, health tech startups beg for clarity

Duchenne breakthrough therapy leaves behind pioneering families

EPA limits use of carcinogenic gas for sterilizing medical devices

explore

Readout Newsletter: Bristol, Sangamo, Gilead, and more

How to save health care price transparency rules

UCLA team creates talking throat patch for voice disorders

Change Healthcare outage fallout shows need for new oversight

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Obamacare plans could cover weight loss drugs

entertainment

knowledge

entertainment

explore